ArrowMark Colorado Holdings’s Impax Laboratories, Inc. IPXL Stock Holding History

ArrowMark Colorado Holdings’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-83	Closed	-$2K	–	503
2016 Q3	$2K	Buy	+83	New	+$2.23K	﹤0.01%	429
2016 Q2	–	Sell	-154,561	Closed	-$4.95M	–	287
2016 Q1	$4.95M	Buy	154,561 +8,185	+6%	+$288K	0.11%	139
2015 Q4	$6.26M	Hold	146,376	–	–	0.17%	128
2015 Q3	$5.15M	Sell	146,376 -5,547	-4%	-$250K	0.14%	145
2015 Q2	$6.98M	Sell	151,923 -115,577	-43%	-$5.49M	0.17%	125
2015 Q1	$12.5M	Buy	267,500 +35,000	+15%	+$1.39M	0.32%	95
2014 Q4	$7.37M	Hold	232,500	–	–	0.19%	126
2014 Q3	$5.51M	Sell	232,500 -21,477	-8%	-$550K	0.15%	148
2014 Q2	$7.62M	Buy	253,977 +103,477	+69%	+$2.79M	0.22%	136
2014 Q1	$3.98M	Buy	+150,500	New	+$3.76M	0.13%	151

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ArrowMark Colorado Holdings's IPXL Position: Q4 2016 in Review

ArrowMark Colorado Holdings sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 83 shares — an estimated $2K sold.

ArrowMark Colorado Holdings first reported a position in IPXL in Q1 2014 and held it in 10 quarters. The position peaked at $12.5M in Q1 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

ArrowMark Colorado Holdings reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
ArrowMark Colorado Holdings sold 83 Impax Laboratories, Inc. shares in Q4 2016, an estimated $2K.
ArrowMark Colorado Holdings first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 10 quarters.
ArrowMark Colorado Holdings's Impax Laboratories, Inc. position peaked at $12.5M in Q1 2015.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.